| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.38 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |